EntroGen, Inc. products

EntroGen RNA Fusion Gene Panel is a complete next generation sequencing (NGS) solution for detecting 307 clinically relevant fusions over 23 genes.

EntroGen NGS Targeted Hotspot Panel is a comprehensive pan-cancer assay designed to detect clinically relevant hotspot mutations in solid tumors.  Utilizing a robust next-generation sequencing (NGS) platform, labs are able to simultaneously analyze several different tumor types by batching up to 12 samples on a single run*.  NGS Targeted Hotspot Panel (THSP) is compatible with fresh frozen, and formalin fixed paraffin embedded (FFPE) samples. This assay features high sensitivity and throughput detecting clinically relevant hotspot variants down to 5% with minimal DNA input.  With its comprehensive, streamlined workflow, THSP is designed to be seamlessly integrated into any lab.  Laboratories with specific challenges, such as low disease specific sample volumes, are able to batch various sample types together and accelerate tumor profiling.